Hematopoietic stem cell transplantation for multiple sclerosis

Archives of Neurology

Volumn 62, Issue 6, 2005, Pages 860-864

  Burt, Richard K ^a   Cohen, Bruce ^a   Rose, John ^b   Petersen, Finn ^b   Oyama, Yu ^a   Stefoski, Dusan ^c   Katsamakis, George ^c   Carrier, Ewa ^d   Kozak, Tomas ^e   Muraro, Paolo A ^f   Martin, Roland ^f   Hintzen, Roger ^g   Slavin, Shimon ^h   Karussis, Dimitrios ^h   Haggiag, Shalom ^h   Voltarelli, Julio C ⁱ   Ellison, George W ^d   Jovanovic, Borko ^a   Popat, Uday ^j   McGuirk, Joseph ^k   Statkute, Laisvyde ^a   Verda, Larissa ^a   Haas, Judith ^l,m   Arnold, Renate ^l,m   more..

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHARLES UNIVERSITY   (Czech Republic)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

ⁱ UNIVERSITY OF SÃO PAULO   (Brazil)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^k Kansas City Cancer Center   (United States)

^l Jewish Hospital   (Germany)

^m CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GADOLINIUM; MELPHALAN; T LYMPHOCYTE RECEPTOR; THYMOCYTE ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN SIZE; EXPANDED DISABILITY STATUS SCALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; MONONUCLEAR CELL; MORBIDITY; MORTALITY; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE; ANIMAL; IMMUNOLOGY; METHODOLOGY;

ANIMALS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MULTIPLE SCLEROSIS;

EID: 20844433202     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.6.860     Document Type: Review

References (25)

1. Burt RK, Burns W, Hess A. Bone marrow transplantation for multiple sclerosis. Bone Marrow Transplant. 1995;16:1-6.
2. Noseworthy JH, Lucchinetti C, Rodriguez M, Weishenker BG. Multiple sclerosis. N Engl J Med. 2000;343:938-952.
3. Burt RK, Padilla J, Begolka WS, Dal Canto MC, Miller SD. Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis. Blood. 1998;91:2609-2616.
4. Karussis DM, Slavin S, Lehmann D, Mizrachi-Koll R. Adamsky O, Ben-Nun A. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol. 1992;148:1693-1698.
5. van Gelder M, van Bekkum DW. Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation. Bone Marrow Transplant. 1996;18:1029-1034.
6. van Gelder M, Mulder AH, van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-mismatched allogeneic bone marrow transplantation. Transplantation. 1996;62:810-818.
7. Karussis DM, Vourka-Karussis U, Lehmann D, et al. Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high-dose cytoreductive treatment followed by syngeneic bone marrow transplantation. J Clin Invest. 1993;92:765-772.
8. van Gelder M, Kinwel-Bohré EP, van Bekkum DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant. 1993;11:233-241.
9. Miller SD, Vanderlugt CL, Begolka WS, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med. 1997;3:1133-1136.
10. Burt RK, Padilla J, Dal Canto MC, Miller SD. Viral hyperinfection of the central nervous system and high mortality after hematopoietic stem cell transplantation for treatment of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Blood. 1999;94:2915-2922.
11. Burt RK, Fassas A, Snowden J, et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant. 2001;28:1-12.
12. Openshaw H, Stuve O, Antel JP, et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology. 2000;54:2147-2150.
13. Monje ML, Mizumatsu S, Fike JR, et al. Irradiation induces neural precursor-cell dysfunction. Nat Med. 2002;8:955-962.
14. Saiz A, Carreras E, Berenguer J, et al. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS. Neurology. 2001;56:1084-1089.
15. Mancardi GL, Saccardi R, Filippi M, et al. Autologous hematopoletic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology. 2001;57:62-68.
16. Muraro PA, Douek DC, Packer A, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med. 2005;201:805-816.
17. Fassas A, Passweg JR, Anagnostopoulos A, et al. Hematopoietic stem cell transplantation for multiple sclerosis: a retrospective multi-center study. J Neurol. 2002;249:1088-1097.
18. Burt RK, Cohen BA, Russell E, et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood. 2003;102:2373-2378.
19. Inglese M, Mancardi GL, Pagani E, et al. Brain tissue loss occur after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J Neurol Neurosurg Psychiatry. 2004;75:643-644.
20. Mancardi GL, Saccardi R, Murialdo A, et al. Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis cases: MRI and clinical data. In: Burt RK, Marmont A, eds. Stem Cell Therapy for Autoimmune Diseases. Georgetown, Tex: Landes Bioscience; 2004:302-307.
21. Kozak T, Havrdova E, Pit'ha J, et al. Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis. Transplant Proc. 2001;33:2179-2181.
22. Openshaw H, Lund BT, Kashyap A, et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biol Blood Marrow Transplant. 2000;6:563-575.
23. Nash RA, Bowen JD, McSweeney PA, et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood. 2003;102:2364-2372.
24. Saccardi R, Mancardi GL, Solari A, et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood. 2005;105:2601-2607.
25. Freedman MS, Atkins HL. Suppressing immunity in advancing MS: too much too late, or too late for much? Neurology. 2004;62:168-169.